Padarthamarai(Tinea corporis)-An oral administration of siddha classical drug Padai sankaaran(External)

A Case series on assessment of effectiveness of padai sankaaran(External) in the treatment of padarthamarai (Tinea corporis) among patients,attending OPD,Government siddha medical college and hospital,Palayamkottai - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070059

Enrollment

Registered

2024-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified Health Condition 2: B354- Tinea corporis

Interventions

Intervention1: Padai sankaaran: Required dosage externally for 30 days Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are having classical symptoms of single or multiple scaly annular lesions, with slightly raised erythematous edge with central clearing in body

Exclusion criteria

Exclusion criteria: Presence of any other skin disease that may affect outcome of study like, 1.Contact dermatitis 2.Nummular eczema 3.Plaque psoriasis

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing the symptoms such as scaling,Itching, erythema,margin continuity in padarthamarai(Tinea corporis) and to determine the therapeutic efficacy of clinical trial drug (Padai sankaaran-External)Timepoint: 30 days	—

Secondary

Measure	Time frame
Changes in the clinical symptoms by using lesion severity score before and after treatmentTimepoint: 30 days	—

Countries

India

Contacts

Public ContactProf Dr T Komalavalli

Government Siddha Medical College and Hospital

drpsk_md@yahoo.in9944337757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026